| Literature DB >> 21998006 |
Kassandra L Munger1, Alberto Ascherio.
Abstract
Observational studies suggest that adequate vitamin D nutrition may reduce the risk of MS and affect the course of the disease. Inherent limitations in these studies, however, preclude a causal interpretation. Randomized controlled clinical trials are the next step to addressing whether vitamin D prevents MS or can favorably affect the course and progression of MS. Here we briefly review the current literature on vitamin D and MS, both as a risk factor and potential treatment for MS with a focus on the issues and challenges in designing prevention and treatment clinical trials.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21998006 PMCID: PMC3351202 DOI: 10.1177/1352458511425366
Source DB: PubMed Journal: Mult Scler ISSN: 1352-4585 Impact factor: 6.312